This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Thursday's Small-Cap Winners Losers

K-Swiss (KSWS) slouched on disappointing financials. The Westlake Village, Calif., maker of apparel and footwear said it earned $10.7 million in the fourth quarter, or 30 cents a share, down from $11.6 million, or 33 cents a share, a year ago. Sales inched up 1.7% to $93.8 million year over year, just past the $92.3 million consensus. Income, however, missed targets by a penny.

Looking ahead, the company is pegging full-year 2007 earnings between $1.20 and $1.50 a share, a far cry from the $2.17 per-share income sought by analysts. Full-year revenue will probably range between $420 million and $460 million, nearly $40 million below the Street projection. Shares were declining $4.05, or 12.1%, to $29.44.

Emergent BioSolutions' (EBS) stock got a black eye on word the biotech company had lost a funding opportunity when the National Institute of Allergy and Infectious Diseases canceled its solicitation for bids to develop a "third-generation anthrax vaccine," to which Emergent had responded after the NIAID issued it last June. Shares were off $1.33, or 8.9%, to $13.70.

G-III Apparel (GIII) cut its revenue forecast to a range of $425 million to $428 million for the year ended Jan. 31, from the prior $430 million, just missing the only analyst's estimate of $429.8 million. The New York-based outerwear maker also reaffirmed its full-year earnings outlook of between 90 cents and 95 cents a share, which resides largely below two analysts' expectations, each of whom is looking for 94 cents a share. These numbers all represent substantial growth from 2005, but shares were losing $3.43, or 13%, to $22.94.

2 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,804.71 -238.19 -1.40%
S&P 500 1,946.16 -26.13 -1.32%
NASDAQ 4,422.0850 -71.3050 -1.59%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs